IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
ANG Lifesciences India Ltd.
Issue Open Date 29-Aug-17  
Issue Closing Date 31-Aug-17  
Application Money 100  
Allotment Money  
Price Band 80 -  
Minimium Application No. 1600  
Issue Size (Shares) 1500800  
Market Lot 1.00  
Objective
The objects of the issue are primarily to raise the capital for following business and operational requirementsof the Company:1. To meet the working capital requirement2. To meet the expenses of the Issue
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors       NA  
Qualified Institutional Buyers       NA  
Retail Individual Investors       NA  
Business Description
Our company ‘ANG Lifesciences Limited’ incorporated in the year 2006, engaged in the business of manufacturingand marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials.Our registered office is located at Darba
more...
Promoter's Holding
Total Share Capital   3680515  
Offered to Public   1500800  
Promoter's Holding (Pre-Issue)   99.94  
Promoter's Holding (Post-Issue)   71  
Address
Darbara Complex
Sco 113
First Floor
District Shopping Centre
B Block Ranjit Avenue
Amritsar ,
Punjab ,
143001
Phone: 0183 5133455 / 5133473
Email: operations@anglifesciences.com
Website: www.anglifesciences.com
Registrar
Bigshare Services Pvt Ltd
G 10 Left Wing Amruta Village
Opp: Yashoda Hospital
Raj Bhavan Road
Somajiguda
Hyderabad
Listed at
BSE
Lead Manager
Guiness Corporate Advisors Pvt Ltd. (Formerly Known As Guiness Merchant Bankers Pvt Ltd)
Promoters
Rajesh Gupta
Saruchi Gupta
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.